ASGR1 and hepatocellular carcinoma: Thus, our data highlights the clinical utility of characterizing CECs using ASGR1/miR-122-5p isolated from patients with chronic liver cirrhosis or HCC to identify potentially more aggressive phenotypes (loss of ASGR1/miR-122-5p) serving as prognostic tool.